The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 9 October 2007, www.theannals.com, DOI 10.1345/aph.1K316.
The Annals of Pharmacotherapy: Vol. 41, No. 11, pp. 1819-1824. DOI 10.1345/aph.1K316
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, E. C
Right arrow Articles by Lin, Y.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, E. C
Right arrow Articles by Lin, Y.-J.

COMPLEMENTARY AND ALTERNATIVE MEDICINE

Lack of Pharmacokinetic Interaction Between St. John's Wort and Prednisone

Edward C Bell, PhD

Assistant Professor, College of Pharmacy & Health Sciences, Texas Southern University, Houston, TX

William R Ravis, PhD FCP

Professor/Head, Department of Pharmacal Sciences, Harrison School of Pharmacy, Auburn University, Auburn, AL

Hui Min Chan, PhD Candidate

Department of Pharmacal Sciences, Harrison School of Pharmacy

Yuh-Jing Lin

Research Fellow, Department of Pharmacal Sciences, Harrison School of Pharmacy

Reprints: Dr. Bell, College of Pharmacy & Health Sciences, Texas Southern University, 3100 Cleburne St., Houston, TX 77004, fax 713/313-1901, bellec{at}tsu.edu

BACKGROUND: St. John's wort (SJW) is a popular dietary supplement involved in numerous dietary supplement-drug interactions with prescription and non-prescription drugs. The supplement has been shown to affect the metabolism of various CYP3A4 substrates. The CYP3A4 pathway mediates the metabolism of a large number of drug entities, including the corticosteroids prednisone and prednisolone.

OBJECTIVE: To examine the effects of long-term SJW administration on the pharmacokinetics of prednisone and its reversible metabolite prednisolone in male subjects.

METHODS: Eight male subjects participated in this single-dose study. The pharmacokinetics of prednisone and prednisolone were evaluated before and after 28 days of SJW administration. Plasma corticosteroid concentrations were determined using a normal phase high-performance liquid chromatography assay. Model-independent methods were used to evaluate corticosteroid pharmacokinetics.

RESULTS: Twenty-eight days of SJW treatment resulted in no significant alterations in the pharmacokinetic parameters for prednisone or prednisolone. Oral administration of prednisone resulted in prednisone mean ± SD area under the curves (AUCs) of 115.89 ± 39.52 µg·h/L prior to SJW treatment and 128.76 ± 32.71 µg·h/L after 28 days of treatment. Prednisolone mean AUCs were 714.19 ± 153.29 µg·h/L before SJW administration and 700.74 ± 89.68 µg·h/L after treatment.

CONCLUSIONS: Concurrent administration of SJW had no significant effect on the single-dose pharmacokinetics of prednisone or metabolic prednisolone in male subjects.

Key Words: cytochrome, metabolism, prednisolone, prednisone, St. John's wort

Published Online, October 9, 2007. www.theannals.com, DOI 10.1345/aph.1K316





homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.